Please assess the completion status of the following clinical trial:

Trial Title: Genetic Predictors of Analgesic Efficacy of Propranolol for Treating Postoperative Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Elective laparoscopic hemicolectomy surgery.~* Self-reported Caucasians.~* ASA (American Society of Anesthesiologists) physical status of I or II.~* Agrees to provide signed and dated informed consent form.~* Willingness to agree with the Biobanking policy.~Exclusion Criteria:~* Uncontrolled medical or psychiatric conditions.~* Severe mental impairment.~* History of major depressive disorder, psychotic disorder or schizophrenia, and/or manic episodes within the past year.~* Active alcoholism within the past 6 months.~* Psychoactive recreational drug abuse within the past 6 months including MDMA, Ketamine, hallucinogens such as LSD and/or sympathomimetics such as Cocaine.~* Inability to comprehend pain assessment.~* Pregnancy and/or breast-feeding.~* Known hypersensitivity to Beta Blockers or Opioids.~* Currently taking Propranolol.~* Currently taking other hypotensive treatments.~* Currently taking Opioids.~* Patients with asthma or reactive airway disease.~* Patients with cardiac arrhythmia, coronary artery disease, congestive heart failure.~* Patients with renal failure or dialysis.~* Patients with liver insufficiency.~* Heart rate less than 60bpm or diastolic blood pressure \<50 mmHg during the preoperative visit.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- IV-PCA morphine + Placebo PO (Type: PLACEBO_COMPARATOR): Pain control after surgery will be performed through IV-PCA morphine. Placebo will be administered with the same schedule of Propranolol in the experimental arm.~Parallel evaluation of Quantitative Sensory Testing (QST), Psychometric assessment and COMT-haplotypes will be included along the trial.
- IV-PCA morphine + Propranolol PO (Type: EXPERIMENTAL): The morning of the surgery a dose of Propranolol 20 mg PO will be administered. After surgery pain control will be performed with IV-PCA morphine; in addition a second dose of Propranolol 20 mg PO will be administered .~During the first and second postoperative day Propranolol 30 mg PO (BID) will be administered. Parallel assessment of Quantitative Sensory Testing (QST), Psychometric assessment and COMT-haplotypes will be included along the trial.

Based on this trial design, predict the completion outcome and termination type (if applicable).